This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Prazosin Hydrochloride (Minipress)

Mary Ellen Kosman, PhD

JAMA. 1977;238(2):157-159.

Abstract
Prazosin hydrochloride is an orally administered vasodilator that recently became available for the treatment of hypertension. It causes less tachycardia than hydralazine but may produce orthostatic hypotension, particularly after the initial dose. The role of prazosin in therapy is limited because of the risk of a first-dose syncopal reaction, and it appears to be indicated primarily in patients who cannot tolerate hydralazine hydrochloride or sympathetic depressant drugs. Like other antihypertensive agents, prazosin should be given with a diuretic.

(JAMA 238:157-159, 1977)

Author Affiliations
Dr Kosman is Senior Scientist, AMA Department of Drugs. This communication was prepared with the assistance of consultants.

Footnotes
Scientific data on prazosin hydrochloride were supplied by Pfizer Laboratories Division, Pfizer Inc, New York.

Reprint requests to Department of Drugs, American Medical Association, 535 N Dearborn, Chicago, IL 60610 (Dr Kosman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prazosin and Clonidine for Moderately Severe Hypertension
Kirkendall et al.
JAMA 1978;240:2553-2556.
ABSTRACT